|
|
Article: Cephalon Launches PROVIGIL(R) (modafinil) in the Republic of Ireland.
- Article from:
- PR Newswire
- Article date:
- February 2, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST CHESTER, Pa., Feb. 2 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today the availability of PROVIGIL(R) (modafinil) tablets in the Republic of Ireland for the treatment of narcolepsy. PROVIGIL is the first pharmaceutical product licensed by the Irish Medicines Board for treatment of this disorder. The company's European subsidiary, Cephalon U.K. Ltd., which currently markets the drug in the United Kingdom, also will market PROVIGIL to sleep specialists and neurologists in Ireland.
Narcolepsy is a chronic, neurological, lifelong sleep disorder that generally begins in young adulthood. Often, 10 to 15 years may pass between onset of symptoms and ...